Feb 28, 2022

Key Considerations in the Optimal Clinical Care of Patients with Small Cell Lung Cancer — Session 2 — Faculty Presentation 1: Selection and Sequencing of Therapy for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) — Dr Luis Paz-Ares

CME information and select...

Feb 28, 2022

Key Considerations in the Optimal Clinical Care of Patients with Small Cell Lung Cancer — Session 2 — Faculty Presentation 2: Recognition and Management of Adverse Events (AEs) with Available SCLC Treatments — Dr Jared Weiss

CME information and select...

Feb 28, 2022

• Introduction (0:00)
• Case: A woman in her late 60s with newly diagnosed extensive-stage small-cell lung cancer (ES-SCLC) who receives carboplatin/etoposide/atezolizumab — Luis Paz-Ares, MD, PhD (13:22)
• Case: A woman in her mid-40s with newly diagnosed ES-SCLC who receives carboplatin/etoposide/durvalumab — Jared...

Feb 25, 2022

Featuring perspectives from Dr Yelena Janjigian, Prof Eric Van Cutsem and Dr Harry Yoon, moderated by Dr Samuel Klempner, including the following topics: 

• Introduction (0:00)
• Current and Future Front-Line Management of Advanced Gastric and Gastroesophageal Junction (GEJ) Cancer — Yelena Y Janjigian,...

Feb 24, 2022

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia — Faculty Presentation 2: Management of Relapsed/Refractory CLL; Novel Investigational Strategies — Dr Lindsey Roeker

CME information and select...